Остани во тек

Najnovija saopštenja za javnost

22.02.2024

Wörwag Pharma: success instead of bottle necks

Böblingen, February 22, 2024 – Wörwag Pharma closed the 2023 financial year with an organic sales growth of 7.6 percent – despite the tense situation…

Прочитајте информации за печатот

22.01.2024

Mauermann becomes Wörwag Pharma Production

Böblingen, January 22, 2024 – With the renaming of the most recent investment Mauermann Arzneimittel GmbH & Co. KG, Wörwag Pharma is taking the next…

Прочитајте информации за печатот

16.03.2023

Wörwag Pharma invests in further growth

Böblingen, March 16, 2023 – The Böblingen-based pharmaceutical and family-owned company Wörwag Pharma closed the 2022 financial year with an increase…

Прочитајте информации за печатот

17.02.2022

[Translate to Macedonian:] Wörwag Pharma invests in own production

Böblingen, February 17, 2022 – The Boeblingen-based family-owned company Wörwag Pharma invested in several strategic milestones in 2021 and…

Прочитајте информации за печатот

13.11.2021

[Translate to Macedonian:] Fritz-Wörwag-Research-Prize: New scientific findings from biofactor research honored

In order to support science and research, Wörwag Pharma has awarded the 10th Fritz Wörwag Research Prize this year. The prize rewards new research…

Прочитајте информации за печатот

04.05.2021

[Translate to Macedonian:] Wörwag Pharma acquires produciton com pany in Poland

Böblingen/Lódz – German pharmaceutical company Wörwag Pharma GmbH & Co. KG announces the acquisition of Sensilab, contract manufacturer and…

Прочитајте информации за печатот

Вашето лице за контакт

Monika Wörwag

Director Communications

press@woerwagpharma.com

Информации за претставниците на медиумите

Новинарите и уредниците можат да ги користат сликите достапни овде бесплатно и само за уреднички цели, под услов да го наведат „Wörwag Pharma“ како извор. Графички промени не се дозволени. Ве молиме испратете ги вашите бесплатни примероци на press@woerwagpharma.com.